cytarabine and losartan potassium

cytarabine has been researched along with losartan potassium in 32 studies

Research

Studies (32)

Timeframe	Studies, this research(%)	All Research%
pre-1990	10 (31.25)	18.7374
1990's	12 (37.50)	18.2507
2000's	6 (18.75)	29.6817
2010's	4 (12.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bedard, DL; Goldwasser, E	1
Eder, M; Ganser, A; Geissler, G; Hess, U; Hoelzer, D; Ottmann, OG; Seipelt, G	1
Ganser, A; Hoelzer, D	2
Ganser, A; Herrmann, F; Hoelzer, D; Lindemann, A; Mertelsmann, R; Oster, W; Ottmann, OG; Seipelt, G	1
Cotes, PM; Hellebostad, M; Marstrander, J; Refsum, HE; Slørdahl, SH	1
Kaku, M; Motomura, S; Nakamura, K; Okano, H	1
Haines, KM; Nicolaides, NC; Stoeckert, CJ	1
Caro, J; Erslev, AJ; Piroso, E	1
Conkie, D; Paul, J	1
Besa, EC; Gardner, FH; Gorshein, D; Hait, WN; Jepson, JH; Leonard, RA	1
Dukes, PP; Ortega, JA	1
Lamerton, LF	1
Boffa, GA; Dumenil, D; Frindel, E; Lucien, N; Winchenne, JJ	1
Milenković, P; Pavlović-Kentera, V	1
Geller, RB; Hillyer, CD; Schultz, AB	1
Daguenel, A; Gorin, NC; Laporte, JP; Lesage, S; Najman, A; Parlier, Y; Woler, M	1
Jelkmann, W; Wolff, M	1
Ariola, C; Catani, L; Fogli, M; Fortuna, A; Lemoli, RM; Leopardi, G; Petrucci, MT; Ricciardi, MR; Rondelli, D; Tafuri, A; Tura, S	1
Ganser, A; Geissler, RG; Schulte, P	1
Ganser, A; Karthaus, M	1
Eriksson, M; Hast, R; Jakovleva, K	1
Blaise, D; Caraux, J; Chabannon, C; Faucher, C; Maraninchi, D; Vey, N	1
Herrera, P; Jodra, MH; Laraña, JG; López, J; Navarro, JL; Odriozola, J; Pérez de Oteyza, J; Ramos, ML; Ramos, P; Roldán, E; Villalón, L; Zamora, C	1
Cailliot, C; Fouillard, L; Gorin, NC; Isnard, F; Labopin, M; Laporte, JP; Lesage, S; Najman, A; Yeshurun, M	1
Chalandon, Y; Helg, C; Stalder, M; Verholen, F	1
Billi, AM; Bortul, R; Cappellini, A; Conte, R; Grafone, T; Mantovani, I; Martelli, AM; Martinelli, G; Tabellini, G; Tazzari, PL	1
Ahmad, I; André, M; Bennani, J; Bron, D; Dargent, JL; Meuleman, N; Ngirabacu, MC; Ravoet, C; Ysebrant, L	1
Gill, D; Keane, C; Marlton, P; Mollee, P	1
Tohyama, K	1
Chen, HR; Chen, P; Guo, Z; He, XP; Liu, XD; Lou, JX; Yang, K; Zhang, Y	1

Reviews

7 review(s) available for cytarabine and losartan potassium

Article	Year
Treatment of myelodysplastic syndromes with cytokines and cytotoxic drugs. Seminars in oncology, 1992, Volume: 19, Issue:2 Suppl 4 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Cytokines; Erythropoietin; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-3; Myelodysplastic Syndromes	1992
Treatment of myelodysplastic syndromes with hematopoietic growth factors. Hematology/oncology clinics of North America, 1992, Volume: 6, Issue:3 Topics: Cytarabine; Drug Synergism; Erythropoietin; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Humans; Interleukin-3; Myelodysplastic Syndromes	1992
The role of bone marrow transplantation in the treatment of myelodysplastic syndromes. Journal of hematotherapy, 1995, Volume: 4, Issue:4 Topics: Bone Marrow Transplantation; Calcitriol; Cytarabine; Erythropoietin; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-3; Isotretinoin; Myelodysplastic Syndromes; Prognosis; Transplantation, Homologous	1995
Clinical use of hematopoietic growth factors in the myelodysplastic syndromes. Seminars in hematology, 1996, Volume: 33, Issue:3 Topics: Cytarabine; Erythropoietin; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Humans; Interleukin-3; Myelodysplastic Syndromes	1996
Clinical use of hematopoietic growth factors in patients with myelodysplastic syndromes. International journal of hematology, 1997, Volume: 65, Issue:4 Topics: Aged; Cytarabine; Erythropoietin; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Humans; Interleukin-3; Interleukin-6; Middle Aged; Myelodysplastic Syndromes; Randomized Controlled Trials as Topic	1997
Clinical use of hematopoietic growth factors in the myelodysplastic syndromes. Leukemia & lymphoma, 1997, Volume: 26 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Erythropoietin; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Humans; Interleukin-3; Interleukin-6; Myelodysplastic Syndromes; Prognosis	1997
[Myelodysplastic syndromes: treatment strategy up-to-date]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:1 Topics: Antilymphocyte Serum; Azacitidine; Benzoates; Cyclosporine; Cytarabine; Deferasirox; Disease Progression; Drug Discovery; Drug Therapy, Combination; Erythropoietin; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Iron Chelating Agents; Lenalidomide; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Quality of Life; Risk Assessment; Thalidomide; Triazoles	2014

Trials

1 trial(s) available for cytarabine and losartan potassium

Article	Year
Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndrome. Biotechnology therapeutics, 1991, Volume: 2, Issue:3-4 Topics: Blood Cell Count; Cytarabine; Erythropoietin; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Cell Growth Factors; Humans; Interleukin-3; Myelodysplastic Syndromes; Recombinant Proteins	1991

Article

Year

Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndrome.

Biotechnology therapeutics, 1991, Volume: 2, Issue:3-4

Topics: Blood Cell Count; Cytarabine; Erythropoietin; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Cell Growth Factors; Humans; Interleukin-3; Myelodysplastic Syndromes; Recombinant Proteins

1991

Other Studies

24 other study(ies) available for cytarabine and losartan potassium

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
On the mechanism of erythropoietin-induced differentiation. XV. Induced transcription restricted by cytosine arabinoside. Experimental cell research, 1976, Oct-15, Volume: 102, Issue:2 Topics: Animals; Bone Marrow; Bone Marrow Cells; Cytarabine; DNA; Erythropoietin; Floxuridine; Hemoglobins; Male; Protein Biosynthesis; Rats; RNA; Transcription, Genetic	1976
Serum immunoreactive erythropoietin in children with acute leukaemia at various stages of disease--and the effects of treatment. European journal of haematology, 1990, Volume: 44, Issue:3 Topics: Adolescent; Anemia; Child; Child, Preschool; Cytarabine; Dose-Response Relationship, Drug; Erythropoietin; Female; Hemoglobins; Humans; Infant; Leukemia, Myeloid, Acute; Longitudinal Studies; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1990
In vitro differentiation of a human erythroid cell line (KMOE) induced by some metabolic inhibitors. Journal of cancer research and clinical oncology, 1985, Volume: 110, Issue:3 Topics: Antimetabolites; Benzidines; Cell Differentiation; Cell Line; Cytarabine; Daunorubicin; Erythrocytes; Erythropoietin; Hemoglobins; Humans; Isoelectric Focusing; Mitomycin; Mitomycins; Radioimmunoassay; Staining and Labeling	1985
Cytosine arabinoside plus hemin treatment of a human erythroid cell line, KMOE, strongly induces embryonic, fetal, and adult beta-like globin genes. Hemoglobin, 1989, Volume: 13, Issue:6 Topics: Aminolevulinic Acid; Cytarabine; Dimethyl Sulfoxide; Drug Synergism; Erythroid Precursor Cells; Erythropoietin; Gene Expression Regulation; Globins; Heme; Hemin; Humans; Leukemia, Erythroblastic, Acute; RNA, Messenger; Stimulation, Chemical; Tumor Cells, Cultured	1989
Inappropriate increase in erythropoietin titers during chemotherapy. American journal of hematology, 1989, Volume: 32, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Erythropoietin; Female; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine	1989
Effects of inhibitors of DNA synthesis on the stimulation of mouse erythroid cells by erythropoietin. Experimental cell research, 1973, Mar-15, Volume: 77, Issue:1 Topics: Animals; Bromodeoxyuridine; Cells, Cultured; Cytarabine; DNA; Erythrocytes; Erythropoietin; Fetus; Floxuridine; Hematopoietic Stem Cells; Heme; Hemoglobins; Hydroxyurea; Iron Isotopes; Liver; Mice; Phosphorus Isotopes; RNA; Stimulation, Chemical; Tritium	1973
Enhanced erythropoietic response in steroid-treated mice. Transactions of the Association of American Physicians, 1973, Volume: 86 Topics: Animals; Cytarabine; Drug Synergism; Erythrocytes; Erythropoiesis; Erythropoietin; Female; Iron; Iron Radioisotopes; Mice; Stimulation, Chemical; Testosterone; Time Factors	1973
Relationship between erythropoietin effect and reduced DNA synthesis in marrow cell cultures. Biochimica et biophysica acta, 1970, Apr-15, Volume: 204, Issue:2 Topics: Animals; Bone Marrow; Bone Marrow Cells; Carbon Isotopes; Culture Techniques; Cytarabine; Depression, Chemical; DNA; Erythropoietin; Glucosamine; Glycine; Heme; Iron; Iron Isotopes; Metabolism; Rats; Sheep; Stimulation, Chemical; Thymidine; Time Factors; Tritium	1970
Adaptation of hemopoietic systems to environmental conditions. Hamatologie und Bluttransfusion, 1970, Volume: 9 Topics: Adaptation, Physiological; Anemia; Animals; Bone Marrow; Cell Division; Cytarabine; Environment; Environmental Exposure; Erythrocytes; Erythropoietin; Hematopoiesis; Hematopoietic Stem Cells; Hematopoietic System; Hypoxia; Iron Isotopes; Methotrexate; Mice; Mitosis; Phenylhydrazines; Rats	1970
Effects of conditioned medium from bone marrow of normal and Ara-C-treated mice on hemoglobin synthesis. Experimental hematology, 1982, Volume: 10, Issue:8 Topics: Animals; Bone Marrow; Cell Differentiation; Culture Media; Cytarabine; Erythropoiesis; Erythropoietin; Hematopoietic Stem Cells; Hemoglobins; Mice; Mice, Inbred Strains	1982
Regeneration of erythroid committed precursor cells in polycythaemic mice treated with cyclophosphamide. Experimental hematology, 1980, Volume: 8, Issue:1 Topics: Animals; Bone Marrow Cells; Cell Division; Colony-Forming Units Assay; Cyclophosphamide; Cytarabine; Erythrocytes; Erythropoiesis; Erythropoietin; Female; Hematopoietic Stem Cells; Mice; Polycythemia; Regeneration; Spleen	1980
Administration of three cytokines instead of bone marrow transplantation in an HIV+ patient with high-grade lymphoma. European journal of haematology, 1994, Volume: 53, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Cytokines; Doxorubicin; Drug Therapy, Combination; Erythropoietin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, AIDS-Related; Melphalan; Prednisolone; Vincristine	1994
Effects of chemotherapeutic and immunosuppressive drugs on the production of erythropoietin in human hepatoma cultures. Annals of hematology, 1993, Volume: 66, Issue:1 Topics: Animals; Antineoplastic Agents; Azathioprine; Colchicine; Cyclophosphamide; Cyclosporine; Cytarabine; Daunorubicin; Erythropoietin; Humans; Ifosfamide; Immunosuppressive Agents; L-Lactate Dehydrogenase; Liver Neoplasms, Experimental; Methotrexate; Organoplatinum Compounds; Tetrazolium Salts; Tumor Cells, Cultured; Vincristine	1993
Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood, 1997, Feb-15, Volume: 89, Issue:4 Topics: Adolescent; Adult; Antigens, CD34; Apoptosis; Blood Component Removal; Cell Cycle; Cell Lineage; Cells, Cultured; Cytarabine; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Interleukin-3; Lenograstim; Male; Middle Aged; Recombinant Proteins; Stem Cell Factor	1997
Aspects on the clinical use of hematopoietic growth factors in myelodysplastic syndromes. Polskie Archiwum Medycyny Wewnetrznej, 1998, Volume: 99, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Cytokines; Daunorubicin; Drug Therapy, Combination; Erythropoietin; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Humans; Myelodysplastic Syndromes; Remission Induction; Thioguanine	1998
Rescue of haemopoiesis by a combination of growth factors including stem-cell factor. Lancet (London, England), 2000, Oct-14, Volume: 356, Issue:9238 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Cytarabine; Epoetin Alfa; Erythrocyte Transfusion; Erythropoietin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Cell Growth Factors; Humans; Lymphoma, Non-Hodgkin; Melphalan; Platelet Transfusion; Recombinant Proteins; Treatment Outcome	2000
Autologous peripheral blood progenitor cell transplantation with <2 x 10(6) CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment. The hematology journal : the official journal of the European Haematology Association, 2000, Volume: 1, Issue:6 Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Caspase 14; Caspases; Cerebral Hemorrhage; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Erythropoietin; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Infections; Leukapheresis; Life Tables; Male; Middle Aged; Neoplasms; Proportional Hazards Models; Transplantation Conditioning; Transplantation, Autologous	2000
A long-term follow-up of 33 patients with non-Hodgkin's lymphoma who received the BEAM high-dose intensification regimen with cytokine support only and no transplant. Leukemia, 2004, Volume: 18, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Drug Therapy, Combination; Erythropoietin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Survival Rate; Time Factors	2004
Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion. European journal of haematology, 2004, Volume: 73, Issue:6 Topics: ABO Blood-Group System; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood Group Incompatibility; Blood Transfusion; Combined Modality Therapy; Cytarabine; Drug Resistance; Erythropoietin; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Killer Cells, Natural; Leukemia, Myelomonocytic, Acute; Leukocyte Transfusion; Male; Middle Aged; Plasmapheresis; Red-Cell Aplasia, Pure; Remission Induction; Rituximab; Transplantation, Homologous	2004
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway. British journal of haematology, 2005, Volume: 129, Issue:5 Topics: Acute Disease; Antigens, CD34; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cells, Cultured; Cytarabine; Drug Resistance, Neoplasm; Erythropoietin; Etoposide; HL-60 Cells; Humans; Leukemia; Leukemia, Myeloid; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Rotenone; Signal Transduction; Stem Cell Factor; Stem Cells	2005
Long-term follow-up of autologous peripheral blood stem cell transplantation in the treatment of a patient with acute panmyelosis with myelofibrosis. Haematologica, 2006, Volume: 91, Issue:12 Suppl Topics: Acute Disease; Anemia, Refractory; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Erythropoietin; Etoposide; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Mitoxantrone; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Primary Myelofibrosis; Recombinant Proteins; Transplantation Conditioning; Transplantation, Autologous; Whole-Body Irradiation	2006
Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population. Annals of hematology, 2011, Volume: 90, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Erythropoietin; Female; Hemoglobins; Humans; Jehovah's Witnesses; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; Remission Induction; Treatment Outcome; Tretinoin	2011
[Clinical analysis of reduced conditioning intensity allo-HSCT treatment for relapsed ETO-positive AML]. Zhongguo shi yan xue ye xue za zhi, 2014, Volume: 22, Issue:5 Topics: Adolescent; Adult; Allografts; Cytarabine; Disease-Free Survival; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Transplantation Conditioning; Vidarabine; Young Adult	2014